CDH1 and cancer: Evaluated levels of ROS may contribute to activating NF-κB signaling, which increases IL-6 production by cancer cells and CAFs, thus facilitating the EMT program by regulating the expression of N-cadherin, E-cadherin, vimentin, Twist and Snail (129).